1. Home
  2. ETON vs BCML Comparison

ETON vs BCML Comparison

Compare ETON & BCML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ETON
  • BCML
  • Stock Information
  • Founded
  • ETON 2017
  • BCML 2004
  • Country
  • ETON United States
  • BCML United States
  • Employees
  • ETON N/A
  • BCML N/A
  • Industry
  • ETON Biotechnology: Pharmaceutical Preparations
  • BCML Major Banks
  • Sector
  • ETON Health Care
  • BCML Finance
  • Exchange
  • ETON Nasdaq
  • BCML Nasdaq
  • Market Cap
  • ETON 428.5M
  • BCML 279.0M
  • IPO Year
  • ETON 2018
  • BCML N/A
  • Fundamental
  • Price
  • ETON $17.21
  • BCML $26.90
  • Analyst Decision
  • ETON Strong Buy
  • BCML
  • Analyst Count
  • ETON 3
  • BCML 0
  • Target Price
  • ETON $27.67
  • BCML N/A
  • AVG Volume (30 Days)
  • ETON 221.4K
  • BCML 28.7K
  • Earning Date
  • ETON 05-13-2025
  • BCML 04-17-2025
  • Dividend Yield
  • ETON N/A
  • BCML 2.28%
  • EPS Growth
  • ETON N/A
  • BCML N/A
  • EPS
  • ETON N/A
  • BCML 2.10
  • Revenue
  • ETON $39,011,000.00
  • BCML $95,714,000.00
  • Revenue This Year
  • ETON $92.33
  • BCML $3.39
  • Revenue Next Year
  • ETON $52.62
  • BCML $6.76
  • P/E Ratio
  • ETON N/A
  • BCML $12.54
  • Revenue Growth
  • ETON 23.29
  • BCML N/A
  • 52 Week Low
  • ETON $3.18
  • BCML $18.54
  • 52 Week High
  • ETON $18.41
  • BCML $30.13
  • Technical
  • Relative Strength Index (RSI)
  • ETON 70.21
  • BCML 66.03
  • Support Level
  • ETON $16.43
  • BCML $26.01
  • Resistance Level
  • ETON $17.49
  • BCML $27.77
  • Average True Range (ATR)
  • ETON 0.85
  • BCML 0.87
  • MACD
  • ETON 0.18
  • BCML 0.14
  • Stochastic Oscillator
  • ETON 98.09
  • BCML 96.56

About ETON Eton Pharmaceuticals Inc.

Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.

About BCML BayCom Corp

BayCom Corp is a bank holding company for United Business Bank. It provides a broad range of financial services to businesses and business owners as well as individuals through its full-service branches and loan production office. The company targets its services to small and medium-sized businesses, professional firms, real estate professionals, nonprofit businesses, labor unions, and related nonprofit entities and businesses and individual consumers. Its products and services include deposit products, personal accounts, loans, online banking, cash management, and business savings services.

Share on Social Networks: